In order to fulfill the ever changing demands of our clients, we are engaged in offering a quality range of 4-Fluoro-2-Methoxy-5-Nitroaniline CAS 1075705-01-9. 4-Fluoro-2-Methoxy-5-Nitroaniline CAS NO 1075705-01-9 widely used to synthesis Mereletinib, an orally available, irreversible, third-generation, mutant-selective epidermal growth factor receptor (EGFR) inhibitora. AZD9291 Intermediates 14192-26-8 is processed under the supervision of our expert professionals using qualitative ingredients and precision tools & machinery to ensure its high purity, safe and reliable.

Thera. Category: EGFR Inhibitor

Cas No.: 1075705-01-9

Synonym: 4-fluoro-2-Methoxy-5-nitroaniline;2-Amino-5-fluoro-4-nitroanisole, 4-Fluoro-5-nitro-o-anisidine;4-Fluoro-2-Methoxy-5-nitrobenzenaMine;Benzenamine, 4-fluoro-2-methoxy-5-nitro-

Molecular Formula:C7H7FN2O3

Molecular Weight:186.1404832

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: AZD9291 Intermediate

Relation Product:

CAS 1421372-66-8, Mutated EGFR-IN-1

CAS 1421372-94-2, N-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine

CAS 1421372-67-9, 1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro-

CAS 1421373-36-5, 3-chloro-N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)propanamid